Kestra Advisory Services’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,161
Closed -$563K 2221
2023
Q1
$563K Sell
5,161
-26,802
-84% -$2.93M 0.01% 1215
2022
Q4
$3.64M Sell
31,963
-34,654
-52% -$3.94M 0.03% 532
2022
Q3
$4.12M Buy
66,617
+26,739
+67% +$1.65M 0.04% 430
2022
Q2
$3.18M Buy
39,878
+7,252
+22% +$578K 0.03% 498
2022
Q1
$3.43M Buy
32,626
+2,614
+9% +$275K 0.04% 487
2021
Q4
$3.23M Buy
30,012
+6,595
+28% +$711K 0.03% 517
2021
Q3
$2.57M Buy
23,417
+3,042
+15% +$333K 0.03% 612
2021
Q2
$1.91M Buy
20,375
+3,919
+24% +$367K 0.02% 670
2021
Q1
$1.52M Sell
16,456
-26,306
-62% -$2.42M 0.02% 693
2020
Q4
$3.09M Buy
42,762
+31,235
+271% +$2.26M 0.04% 458
2020
Q3
$895K Buy
+11,527
New +$895K 0.02% 664